RecallDepth
Class II Terminated

Fexofenadine HCl Tablets, USP, 180 mg, packaged in a) 30-count bottles (NDC 0378-0782-93) and b) 500-count bottles (NDC 0378-0782-05); Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA.

This recall has been terminated (originally issued February 6, 2019).

Company
Mylan Pharmaceuticals Inc.
Recall Initiated
January 18, 2019
Posted
February 6, 2019
Recall Number
D-0428-2019
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
88,090 bottles
Firm Location
Morgantown, WV, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Impurities/Degradation Specifications: Related compound results obtained during routine stability testing was slightly elevated above specification.

Distribution

Nationwide in the USA

Lot / Code Info

Lot #: a) 3085490, 3085491, Exp 04/19; b) 3085492, 3085493, 3085494, 3085495, 3085496, Exp 04/19

More recalls by Mylan Pharmaceuticals Inc.

View all recalls by this company →

Other recent Class II Drug recalls